Literature DB >> 26546751

Recent advances of cocktail chemotherapy by combination drug delivery systems.

Quanyin Hu1, Wujin Sun1, Chao Wang1, Zhen Gu2.   

Abstract

Combination chemotherapy is widely exploited for enhanced cancer treatment in the clinic. However, the traditional cocktail administration of combination regimens often suffers from varying pharmacokinetics among different drugs. The emergence of nanotechnology offers an unparalleled opportunity for developing advanced combination drug delivery strategies with the ability to encapsulate various drugs simultaneously and unify the pharmacokinetics of each drug. This review surveys the most recent advances in combination delivery of multiple small molecule chemotherapeutics using nanocarriers. The mechanisms underlying combination chemotherapy, including the synergistic, additive and potentiation effects, are also discussed with typical examples. We further highlight the sequential and site-specific co-delivery strategies, which provide new guidelines for development of programmable combination drug delivery systems. Clinical outlook and challenges are also discussed in the end.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Chemotherapy; Combination; Drug delivery; Nanocarriers

Mesh:

Year:  2015        PMID: 26546751      PMCID: PMC4998845          DOI: 10.1016/j.addr.2015.10.022

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  186 in total

Review 1.  P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.

Authors:  D Nielsen; T Skovsgaard
Journal:  Biochim Biophys Acta       Date:  1992-07-07

2.  Combinatorial drug conjugation enables nanoparticle dual-drug delivery.

Authors:  Santosh Aryal; Che-Ming Jack Hu; Liangfang Zhang
Journal:  Small       Date:  2010-07-05       Impact factor: 13.281

3.  Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.

Authors:  Sang-Min Lee; Thomas V O'Halloran; SonBinh T Nguyen
Journal:  J Am Chem Soc       Date:  2010-11-15       Impact factor: 15.419

Review 4.  Magnetic nanoparticles in MR imaging and drug delivery.

Authors:  Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

Review 5.  Exploring the tumor microenvironment with nanoparticles.

Authors:  Lei Miao; Leaf Huang
Journal:  Cancer Treat Res       Date:  2015

Review 6.  Paclitaxel (Taxol): a success story with valuable lessons for natural product drug discovery and development.

Authors:  G M Cragg
Journal:  Med Res Rev       Date:  1998-09       Impact factor: 12.944

7.  Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies.

Authors:  Hans-Peter Gerber; Napoleone Ferrara
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

Review 8.  Irinotecan and its active metabolite, SN-38: review of bioanalytical methods and recent update from clinical pharmacology perspectives.

Authors:  Mullangi Ramesh; Preeti Ahlawat; Nuggehally R Srinivas
Journal:  Biomed Chromatogr       Date:  2010-01       Impact factor: 1.902

Review 9.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

Review 10.  Single agent versus combination chemotherapy for metastatic breast cancer.

Authors:  Sue Carrick; Sharon Parker; Charlene E Thornton; Davina Ghersi; John Simes; Nicholas Wilcken
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15
View more
  93 in total

1.  Nano-Co-Delivery of Berberine and Anticancer Drug Using PLGA Nanoparticles: Exploration of Better Anticancer Activity and In Vivo Kinetics.

Authors:  Iliyas Khan; Gaurav Joshi; Kartik T Nakhate; Raj Kumar; Umesh Gupta
Journal:  Pharm Res       Date:  2019-08-16       Impact factor: 4.200

2.  Chitosan Hydrogels for Synergistic Delivery of Chemotherapeutics to Triple Negative Breast Cancer Cells and Spheroids.

Authors:  John D Schneible; Ashlyn T Young; M A Daniele; S Menegatti
Journal:  Pharm Res       Date:  2020-07-13       Impact factor: 4.200

3.  Electrical stimulation prevents doxorubicin-induced atrophy and mitochondrial loss in cultured myotubes.

Authors:  Blas A Guigni; Dennis K Fix; Joseph J Bivona; Bradley M Palmer; James A Carson; Michael J Toth
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-18       Impact factor: 4.249

Review 4.  Nanoformulations for combination or cascade anticancer therapy.

Authors:  Lei Miao; Shutao Guo; C Michael Lin; Qi Liu; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2017-06-15       Impact factor: 15.470

Review 5.  Advances in engineering local drug delivery systems for cancer immunotherapy.

Authors:  Peter Abdou; Zejun Wang; Qian Chen; Amanda Chan; Daojia R Zhou; Vivienne Gunadhi; Zhen Gu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-04-07

Review 6.  Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.

Authors:  Fanfei Meng; Ning Han; Yoon Yeo
Journal:  Expert Opin Drug Deliv       Date:  2016-08-08       Impact factor: 6.648

Review 7.  Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2.

Authors:  Lindsay K Caesar; Nadja B Cech
Journal:  Nat Prod Rep       Date:  2019-06-19       Impact factor: 13.423

8.  Cancer systems biology: Harnessing off-target effects.

Authors:  Gaye Saginc; Franziska Voellmy; Rune Linding
Journal:  Nat Chem Biol       Date:  2017-11-21       Impact factor: 15.040

9.  Local delivery of checkpoints antibodies.

Authors:  Chao Wang; Yanqi Ye; Zhen Gu
Journal:  Hum Vaccin Immunother       Date:  2016-09-26       Impact factor: 3.452

10.  Camouflaging Nanoparticles for Ratiometric Delivery of Therapeutic Combinations.

Authors:  Fanfei Meng; Jianping Wang; Qineng Ping; Yoon Yeo
Journal:  Nano Lett       Date:  2019-02-07       Impact factor: 11.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.